m6A methylases that participate in cancer glycolytic metabolic pathways

m6A methylases that participate in cancer glycolytic metabolic pathways. Cancer cells rely on glycolytic pathways to meet their energy needs for growth and proliferation, and m6A-associated enzymes participate in the cancer glycolytic pathway. The m6A methyltransferase METTL3 is able to promote glycolysis and tumor progression through m6A modification-mediated downstream targets (PDK4, GLUT1, HK2, GLUT1, GLUT4 and ENO2). METTL14 inhibits glycolysis and tumor progression by accelerating the degradation of BPTF mRNA. WTAP is able to mediate the glycolytic process of tumors and promote tumor progression through either upregulating ENO1 expression or enhancing the stability of HK2 mRNA in an m6A-dependent manner. ALKBH5 has a dual effect on the glycolytic pathway, on one hand attenuating CK2α, and on the other hand increasing the stability of GLUT4 mRNA, thereby promoting the glycolysis of breast cancer cells. FTO inhibits glycolysis and thyroid cancer growth by reducing the stability of apoE mRNA in an m6A-dependent manner. Finally, YTHDF1 enhances glycolysis by improving the protein translation of PKM2, thereby promoting the progression of breast cancer. apoE, apolipoprotein E; METTL3/4, methyltransferase-like 3/4; WTAP, Wilms tumor 1-associated protein; FTO, fat mass and obesity-associated protein; ALKBH5, α-ketoglutarate-dependent dioxygenase homolog 5; PDK4, pyruvate dehydrogenase kinase 4; GLUT1/4, glucose transporter 1/4; YTHDF1/2/3, YTH domain family protein 1/2/3; HK2, hexokinase 2; ENO2, enolase 2; BPTF, bromodomain PHD finger transcription factor; CK2α, casein kinase 2α; m6A, N6-methyladenosine; PKM2, pyruvate kinase M2; ENO2, enolase 2
m6A methylases that participate in cancer glycolytic metabolic pathways

Publication

Mechanisms of N6-methyladenosine modification in tumor development and potential therapeutic strategies (Review) (2023) Xi Pu, et al. Int J Oncol. 2023 Jun;62(6). Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates PDK4 PDK4 ncbigene_symbol PDK4 5166
Homo sapiens Primates METTL3 METTL3 ncbigene_symbol METTL3 56339
Homo sapiens Primates METTL14 METTL14 ncbigene_symbol METTL14 57721
Homo sapiens Primates GLUT4 GLUT4 ncbigene_synonym SLC2A4 6517
Homo sapiens Primates ENO2 ENO2 ncbigene_symbol ENO2 2026
Homo sapiens Primates GLUT1 GLUT1 ncbigene_synonym SLC2A1 6513
Homo sapiens Primates HK2 HK2 ncbigene_symbol HK2 3099
Homo sapiens Primates HK2 HK2 ncbigene_synonym KCNA5 3741
Homo sapiens Primates HK2 HK2 ncbigene_synonym KIF2A 3796
Homo sapiens Primates HK2 HK2 ncbigene_synonym KLK2 3817
Homo sapiens Primates HK2 HK2 ncbigene_synonym HOOK2 29911
Homo sapiens Primates WTAP WTAP ncbigene_symbol WTAP 9589
Homo sapiens Primates ΕΝΟΙ ENO famplex_relations ENO1 2023
Homo sapiens Primates ΕΝΟΙ ENO famplex_relations ENO3 2027
Homo sapiens Primates ΕΝΟΙ ENO famplex_relations ENO4 387712
Homo sapiens Primates BPTF BPTF ncbigene_symbol BPTF 2186
Homo sapiens Primates ALKBH5 ALKBH5 ncbigene_symbol ALKBH5 54890
Homo sapiens Primates FTO FTO ncbigene_symbol FTO 79068
Homo sapiens Primates PKM2 PKM2 ncbigene_synonym PKM 5315
Homo sapiens Primates PKM2 PKM2 famplex_relations PKLR 5313
Homo sapiens Primates YTHDF1 YTHDF1 ncbigene_symbol YTHDF1 54915

Chemical mentions

Word Match MeSH Name ChEBI
thyroid Thyroid chebi:9584

Disease mentions

Word Match MeSH Name DOID
cancer cancer cancer DOID:162
cancer cancer cancer DOID:162
carcinoma carcinoma carcinoma DOID:305
cancer cancer cancer DOID:162
cancer cancer cancer DOID:162
cancer cancer cancer DOID:162
carcinoma carcinoma carcinoma DOID:305
cancer cancer cancer DOID:162
cancer cancer cancer DOID:162
carcinoma carcinoma carcinoma DOID:305
cancer cancer cancer DOID:162
Breast cancer breast cancer breast cancer DOID:1612
Colorectal cancer colorectal cancer colorectal cancer DOID:9256
Breast cancer breast cancer breast cancer DOID:1612
Papillary carcinoma papillary carcinoma papillary carcinoma DOID:3113
Renal cell carcinoma renal cell carcinoma renal cell carcinoma DOID:4450